The story of Viagra, and its creator copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its exclusivity period created a deluge of lower-priced alternatives , significantly diminishing its market share . While specific businesses may attempt to capitalize on similar conditions , t